The versatility of induced pluripotent stem cells in regenerative medicine, disease modeling, drug discovery, and personalized therapy underpins their growing demand. Additionally, advancements in ...
A group of scientists says they will bring back the woolly mammoth by late 2028, and they just announced that they raised ...
Colossal Biosciences, which aims to revive extinct species, announced it has raised an additional $200 million. Critics say ...
Colossal BioSciences has raised $200 million in a new round of funding to bring back extinct species like the woolly mammoth.
A group of scientists says they will bring back the woolly mammoth by late 2028, and they just announced that they raised ...
In BlueAllele Corp. v. Intellia Therapeutics, Inc., 2024 U.S. Dist. Lexis 222094 (D. Del. Dec. 9, 2024)1, the District of ...
CRISPR gene-editing technology presents a possible solution for feeding a growing population, but incorporating CRISPR into ...
Colossal, a leading biosciences company working to combat environmental dangers and revive extinct species, has reached a new ...
CRISPR screening libraries are collections of carefully designed single-guide RNAs (sgRNAs) that allow researchers to ...